Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Chubb
Farmers Insurance
Mallinckrodt
Queensland Health
Julphar
McKesson
AstraZeneca
Medtronic
Merck

Generated: October 21, 2017

DrugPatentWatch Database Preview

Cariprazine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for cariprazine hydrochloride and what is the scope of cariprazine hydrochloride freedom to operate?

Cariprazine hydrochloride
is the generic ingredient in one branded drug marketed by Forest Res Inst Inc and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Cariprazine hydrochloride has seventy patent family members in thirty-five countries.

There is one drug master file entry for cariprazine hydrochloride. One supplier is listed for this compound.

Summary for Generic Name: cariprazine hydrochloride

US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: see list1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list9
Clinical Trials: see list2,306
Patent Applications: see list31
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cariprazine hydrochloride at DailyMed

Pharmacology for Ingredient: cariprazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-001Sep 17, 2015RXYesNo► Subscribe► Subscribe► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-001Sep 17, 2015RXYesNo► Subscribe► SubscribeYY ► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-002Sep 17, 2015RXYesNo► Subscribe► Subscribe► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-003Sep 17, 2015RXYesNo► Subscribe► SubscribeYY ► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-001Sep 17, 2015RXYesNo► Subscribe► SubscribeYY ► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-003Sep 17, 2015RXYesNo► Subscribe► Subscribe► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-003Sep 17, 2015RXYesNo► Subscribe► SubscribeYY ► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-004Sep 17, 2015RXYesYes► Subscribe► SubscribeYY ► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-002Sep 17, 2015RXYesNo► Subscribe► SubscribeYY ► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-004Sep 17, 2015RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: cariprazine hydrochloride

Country Document Number Estimated Expiration
South Africa200907511► Subscribe
BrazilPI0413283► Subscribe
South Africa200601026► Subscribe
TaiwanI424846► Subscribe
Morocco31434► Subscribe
Spain2628025► Subscribe
Japan3999806► Subscribe
Hungary0302451► Subscribe
Slovenia1663996► Subscribe
South Korea20100018493► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
Moodys
Queensland Health
Chubb
Deloitte
Federal Trade Commission
Teva
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot